FB Posts

The Trump administration on Monday moved to require drugmakers to disclose prices in consumer ads, just hours after branding a pharmaceutical industry transparency plan as inadequate.

HHS said its proposed rule fulfilled another prong of the president’s blueprint to address pharmaceutical costs and would help Americans make more informed decisions that could lower out-of-pocket costs and those of government health programs like Medicare and Medicaid. The move came with polls showing significant voter outrage about drug costs, which also are comprising an ever larger share of the federal budget.

Trump issues rule to require drug prices in TV ads, rejecting industry plan

PhRMA said it could not require companies to follow a standard format for determining what cost information to share and how it is presented.


Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment

This site uses Akismet to reduce spam. Learn how your comment data is processed.